Prevalence of auricular thrombosis before atrial flutter cardioversion: A 17-year transoesophageal echocardiographic study

Europace

Volumn 18, Issue 3, 2016, Pages 450-456

  Cresti, Alberto ^a   García Fernández, Miguel Angel ^b   De Sensi, Francesco ^a   Miracapillo, Gennaro ^a   Picchi, Andrea ^a   Scalese, Marco ^c   Severi, Silva ^a  

^a MISERICORDIA HOSPITAL   (Italy)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atrial fibrillation; Atrial flutter; Atrial thrombosis; Cardioversion; Left appendage; Right appendage; Transoesophageal echocardiography

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOVERSION; COMPARATIVE STUDY; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FLUTTER; HEART ATRIUM THROMBOSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; PREVALENCE; PRIORITY JOURNAL; REAL TIME ULTRASOUND SCANNER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ATRIAL FLUTTER; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; INCIDENCE; ITALY; MIDDLE AGED; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; THROMBOSIS; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SEVERITY OF ILLNESS INDEX; THROMBOSIS; TIME FACTORS;

EID: 84965143454     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv128     Document Type: Article

References (53)

1. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976;53:273-9.
2. Klein AL, Murray D, Grimm RA. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 2001;37:691-704.
3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146:857-67.
4. Camm JA, Kirchhof P, Lip GYH, Schotten U, Savalieva I, Ernst S et al. Guidelines for the management of atrial fibrillation. the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12: 1360-420.
5. JanuaryCT,Wann LS, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE et al. 2014AHA/ACC/HRS Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014;130: 2071-104.
6. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or flutter. J Am Coll Cardiol 1992;19:851-5.
7. Omran H, JungW, Rabahieh R, MacCarter D, Illien S, Rang B et al. Left appendage function in patients with atrial flutter. Heart 1997;78:250-4.
8. Silverman DI, Manning WJ. Prophylactic anticoagulation of atrial flutter prior to cardioversion: meeting the burden of proof. Am J Med 2001;11:493-4.
9. Corrado G, Sgalambro A, Mantero A, Gentile M, Gasparini M, Bufalino R et al. Thromboembolic risk in atrial flutter. the FLASIEC (FLutter Atriale Società Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J 2001;22:1042-51.
10. Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, AsingerRW, Black IW et al. Use of transesophageal echocardiography to guide cardioversion in atrial fibrillation. N Eng J Med 2001;344:1411-20.
11. García-Fernández MA, Torrecilla EG, San Román D, Azevedo J, Bueno H, Moreno MM et al. Left atrial appendage Doppler flow patterns: implications on thrombus formation. Am Heart J 1992;124:955-61.
12. González-Torrecilla E, García-Fernández MA, Pérez-David E, Bermejo J, Moreno M, Delcán JL. Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation. Am J Cardiol 2000;86:529-34.
13. Roijer A, Eskilsson J, Olsson B. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Eur Heart J 2000;21:837-47.
14. Stoddard MF, Dawkins P, Prince CR, Longaker RA. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. Am Heart J 1995;129:1204-15.
15. Schmidt H, von der Recke G, Illien S, Lewalter T, Schimpf R,Wolpert C et al. Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol 2001;38:778-84.
16. Bikkina M, Alpert MA, Mulekar M, Shakoor A, Massey CV, Covin A. Prevalence of intraatrial thrombus in patients with atrial flutter. Am J Cardiol 1995;76:186-9.
17. Cresti A, García-Fernández MA, Miracapillo G, Picchi A, Cesareo F, Guerrini F et al. Frequency and significance of Right Atrial Appendage Thrombosis in patients with persistent atrial fibrillation or atrial flutter. J Am Soc Echocardiogr 2014;27:1200-7.
18. Fatkin D, Herbert E, Feneley MP. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 1994;73:672-6.
19. Santiago D,Warshofsky M, Li Mandri G, Di Tullio M, Coromilas J, Reiffel J et al. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study. J Am Coll Cardiol 1994;24:159-64.
20. Sakurai K, Tadakazu H, Nakagawa K, Kameyama T, Nozawa T, Asanoi H et al. Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter. Chest 2003;124:1670-4.
21. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiography facilitated early cardioversion from atrial fibrillation using shortterm anticoagulation: final results of a prospective 4.5-study. J Am Coll Cardiol 1995;25:1354-61.
22. WyseDG,Waldo AL, Di Marco JP, Domanski MJ, RosenbergY, Schron EB et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
23. Mitchell MA, Hughes GS, Ellenbogen KA, Leonard LB, Dietrich C, Sargent DA et al. Cardioversion related stroke rates in atrial fibrillation and atrial flutter. Circulation 1997;96(suppl I):I-453. Abstract.
24. Chalasani P, Cambre S, Silverman ME. Direct-current cardioversion for the conversion of atrial flutter. Am J Cardiol 1996;77:658-60.
25. Mehta D, Baruch L. Thromboembolism following cardioversion of ' common' atrial flutter. Risk factors and limitations of transesophageal echocardiography. Chest 1996;110:1001-3.
26. Grimm RA, Tsui KL, Vaughn SE, Agler DA, Scalia GM, Ching MK et al. TEE-guided early cardioversion of atrial flutter: results from the Acute Trial registry. Circulation 1997;96(suppl I):I-25 Abstract.
27. Irani WN, Grayburn PA, Afridi I. Prevalence of thrombus, spontaneous echo contrast and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography. Circulation 1997;95:962-6.
28. Bertaglia E, D'Este D, Franceschi M, Pascotto P. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism. Ital Heart J 2000;1:349-53.
29. Seidl K, Rameken M, Drögemuller A, Vater M, Brandt A, Schwacke H et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. J AmColl Cardiol 2002;39:1436-42.
30. Gallagher MM, Hennessy BJ, Edvardsson N, Hart CM, Shannon MS, Obel OA et al. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol 2002;40:926-33.
31. Elhendy A, Gentile F, Khandheria BK, Gersh BJ, Bailey KR, Montgomery SC et al. Thromboembolic complications after electrical cardioversion in patients with atrial flutter. Am J Med 2001;111:433-8.
32. Gaibazzi N, Piepoli M. TEE screening in atrial flutter: A single-centre experience with retrospective validation of a new risk score for the presence of atrial thrombi. Int J Cardiol 2008;129:149-51.
33. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010;137: 263-72.
34. Parikh MG, Aziz Z, Krishnan K, Madias C, Trohman RG. Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter. Am J Cardiol 2012;109:550-5.
35. Maltagliati A, Galli CA, Tamborini G, Celeste F, Muratori M, Pepi M. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography. J Cardiovasc Med 2009;10:523-8.
36. Demir AD, Soylu M, Ozdemir O, Topaloglu S, Aras D, Sasmaz A et al. Do different atrial flutter types carry the same thromboembolic risk. Angiology 2005;56:593-9.
37. Alyeshmerni D, Pirmohamed A, Barac A, Smirniotopoulos J, Xue E, Goldstein S et al. Transesophageal echocardiographic screening before atrial flutter ablation: is it necessary for patient safety? J Am Soc Echocardiogr 2013;26:1099-105.
38. Grönefeld GC,Wegener F, Israel CW, Teupe C, Hohnloser SH. Thromboembolic risk of patients referred for radiofrequency catheter ablation of typical atrial flutter without prior appropriate anticoagulation therapy. Pacing Clin Electrophysiol 2003;26: 323-7.
39. Takami M, Suzuki M, Sugi K, Ikeda T. Time course for resolution of left atrial appendage stunning after catheter ablation of chronic atrial flutter. J AmColl Cardiol 2003;41: 2207-11.
40. Sparks PB, Kalman JM. Is atrial flutter a risk factor for stroke? J AmColl Cardiol 2001;38: 785-8.
41. Stoddard MF. Risk of thromboembolism in acute atrial fibrillation or atrial flutter. Echocardiography 2000;17:393-405.
42. Jordaens L, Missault L, Germonpré E, Callens B, Adang L, Vandenbogaerde J et al. Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion. Am J Cardiol 1993;71:63-7.
43. Grimm RA, Stewart WJ, Arheart K, Thomas JD, Klein AL. Left atrial appendage 'stunning' after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol 1997;29:582-9.
44. Tunick PA, McEthinney L, Mitchell T, Kronzon I. the alternation between atrial flutter and atrial fibrillation. Chest 1992;101:34-6.
45. Delise P, Sitta N, Corò L, Marras E, Sciarra L, BocchinoMet al.Commonatrial flutter and atrial fibrillation are not always two stages of the same disease. A long-term follow-up study in patients with atrial flutter treated with cavo-tricuspid isthmus ablation. J Cardiovasc Med 2006;7:800-5.
46. Scholten MF, Thornton AS, Mekel JM, Koudstaal PJ, Jordaens LJ. Anticoagulation atrial fibrillation and flutter. Europace 2005;7:492-9.
47. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al.; the RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
48. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, HackeWet al.; the ROCKET AF Steering Committee for theROCKETAF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91.
49. Granger CB, Alexander JH,McMurray JJ, Lopes RD, Hylek EM, HannaMet al.; for the ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92.
50. Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S et al.; for the AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806-17.
51. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL. Edoxaban versus warfarin in patients with atrial fibrillation. N Eng J Med 2013;369:2093-104.
52. Cappato R, Ezekowitz MD, Klein AL, Camm AJ, Ma CS, Le Heuzey JY et al.; X-VeRT Investigators. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation. Eur Heart J 2014;35:3346-55.
53. Tops LF, Schalij MJ, Bax J. Imaging and atrial fibrillation: The role of multimodality imaging in patient evaluation and management of atrial fibrillation. Eur Heart J 2010;31:542-51.